Vesilut — EU research guide.
Vesilut is a Khavinson-series peptide bioregulator originally derived from urinary bladder tissue, studied for bladder cell function and urogenital aging research. It overlaps in proposed target tissue with Chitomur, another bladder-focused bioregulator in the same family.
What is Vesilut?
Vesilut is a Khavinson-series peptide bioregulator originally derived from urinary bladder tissue, studied for bladder cell function and urogenital aging research. It overlaps in proposed target tissue with Chitomur, another bladder-focused bioregulator in the same family.
What does the research show?
Published data is limited to small animal and Eastern European cohort studies. No independently replicated controlled human trials are publicly available as of mid-2026.
EU legal status
Not approved as a medicine anywhere in the EU. Available only from a small number of specialist research vendors.
Molecular information
Pharmacokinetics
Vesilut is not yet in our price comparison
We expand EU supplier coverage every month.